Proceedings of the 2019 Canadian Inflammatory Myopathy Study Symposium: Clinical Trial Readiness in Myositis.
Proceedings of the 2019 Canadian Inflammatory Myopathy Study Symposium: Clinical Trial Readiness in Myositis.
J Rheumatol. 2020 Jun 15;:
Authors: Leclair V, Landon-Cardinal O, Aggarwal R, Bansback N, Campbell C, Feldman BM, Jarry M, McNamara S, White B, Hudson M, CIMS Investigators
Abstract
The Canadian Inflammatory Myopathy Study (CIMS) is a multicenter prospective cohort recruiting in 8 centers across Canada. One of the aims of CIMS is to conduct and participate in clinical trials in autoimmune inflammatory myopathies (AIM). Conducting clinical trials in rare diseases such as AIM presents challenges. During this symposium, experts in the field presented different solutions to successfully conduct clinical trials in AIM, including the importance of collaboration and careful trial design, as well as training and mentoring of young investigators.
PMID: 32541080 [PubMed - as supplied by publisher]
Source: J Rheumatol - Category: Rheumatology Authors: Leclair V, Landon-Cardinal O, Aggarwal R, Bansback N, Campbell C, Feldman BM, Jarry M, McNamara S, White B, Hudson M, CIMS Investigators Tags: J Rheumatol Source Type: research
More News: Autoimmune Disease | Canada Health | Clinical Trials | Men | Rare Diseases | Rheumatology | Study | Training | Universities & Medical Training